Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.

doi:10.1200/JCO.2011.39.7638

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jan 2013

Rosenthal Adam N, Fraser Lindsay, Manchanda Ranjit, Badman Philip, Philpott Susan, Mozersky Jessica, Hadwin Richard, Cafferty Fay H, Benjamin Elizabeth, Singh Naveena, Evans D Gareth, Eccles Diana M, Skates Steven J, Mackay James, Menon Usha, Jacobs Ian J

Abstract excerpt

PURPOSE: To establish the performance characteristics of annual transvaginal ultrasound and serum CA125 screening for women at high risk of ovarian/fallopian tube cancer (OC/FTC) and to investigate the impact of delayed screening interval and surgical intervention. PATIENTS AND METHODS: Between May 6, 2002, and January 5, 2008, 3,563 women at an estimated ≥ 10% lifetime risk of OC/FTC were recruited and screened...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ovarian Epithelial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Fallopian Tube Neoplasms

Share to Guideline Adherence

Share to Mass Screening

Share to Neoplasm Grading

Share to Neoplasms, Glandular and Epithelial

Share to Peritoneal Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 23213100
DOI: 10.1200/JCO.2011.39.7638
PMCID: PMC3530690

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.PMID 23213100Read ↗

The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance.Semantic proximity Read ↗

Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.Semantic proximity Read ↗

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.Semantic proximity Read ↗

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.Semantic proximity Read ↗

Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United StatesSemantic proximity Read ↗

Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective.Semantic proximity Read ↗

Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.Semantic proximity Read ↗

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.Semantic proximity Read ↗

Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system.Semantic proximity Read ↗

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2.Semantic proximity Read ↗

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.Semantic proximity Read ↗

Ten-Year Follow-Up of Women at High Risk for Familial Breast and Ovarian Cancer in Otago and Southland, New Zealand.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.